Global Hydronephrosis Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

 Hydronephrosis Market Size      

• The global hydronephrosis market size was valued at USD 3.53 billion in 2024 and is expected to reach USD 7.37 billion by 2032, at a CAGR of 9.64% during the forecast period
• This growth is driven by factors such as the rising prevalence of kidney-related disorders, aging population, and technological advancements in diagnostics

Hydronephrosis Market Analysis

• Hydronephrosis is a condition characterized by the swelling of a kidney due to a build-up of urine, often caused by an obstruction in the urinary tract
• The global hydronephrosis market is experiencing significant growth, driven by factors such as the increasing prevalence of kidney-related disorders, advancements in diagnostic imaging technologies, and rising healthcare expenditures
• North America is expected to dominate the global hydronephrosis market, accounting for approximately 42.6% of the market revenue. This dominance is attributed to advanced healthcare infrastructure, high adoption of innovative surgical technologies, and significant healthcare expenditure
• Asia-Pacific is expected to be the fastest growing region in global hydronephrosis market with 30.3% market share, driven by increasing healthcare investments, rising awareness about urinary tract disorders, and a growing geriatric population in countries such as China, India, and Japan
• Shock wave lithotripsy segment is expected to dominate the market with a market share of 40.5% in 2025. This dominance is attributed to its non-invasive nature, high efficacy in treating kidney stones—a leading cause of hydronephrosis—and increasing patient preference for procedures with minimal discomfort and shorter recovery times

Report Scope and Hydronephrosis Market Segmentation     

Hydronephrosis Market Trends

“Advancements in Diagnostic Imaging and Minimally Invasive Treatments for Hydronephrosis”

• One prominent trend in the management of hydronephrosis is the increasing adoption of advanced diagnostic imaging techniques and minimally invasive treatment modalities
• These innovations enhance diagnostic accuracy and therapeutic outcomes by enabling early detection and effective management of urinary tract obstructions
• Advanced imaging techniques such as Magnetic Resonance Urography (MRU) offer high sensitivity and specificity in detecting and grading hydronephrosis, as well as identifying the location of obstruction when present. This accuracy makes MRU a valuable tool in diagnosing and monitoring hydronephrosis 
• These advancements are transforming the diagnosis and treatment of hydronephrosis, improving patient outcomes, and driving the demand for next-generation diagnostic and therapeutic solutions

Hydronephrosis Market Dynamics

Driver

“Rising Prevalence of Kidney Diseases and Urinary Tract Obstructions”

• The increasing incidence of kidney-related disorders, including kidney stones, urinary tract infections, and congenital anomalies, is a significant driver for the hydronephrosis market
• The aging global population is more susceptible to conditions leading to hydronephrosis, such as benign prostatic hyperplasia and other urinary tract obstructions

For instance,

• According to Kidney Research UK, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population  
• This growing patient population necessitates effective diagnostic and treatment solutions, thereby propelling market growth

Opportunity

“Integration of Artificial Intelligence in Diagnostic Imaging”

• The incorporation of artificial intelligence (AI) into diagnostic imaging techniques, such as ultrasound and MRI, offers enhanced accuracy and efficiency in detecting hydronephrosis
• AI algorithms can assist in the early detection and grading of hydronephrosis by analyzing imaging data, leading to timely and precise interventions

For example,

• AI-aided ultrasound has shown promise in improving the diagnosis accuracy of renal diseases, including hydronephrosis, by providing quantitative diagnostic information and reducing interobserver variability 
• The integration of AI in diagnostic procedures can lead to improved patient outcomes and streamlined clinical workflows

Restraint/Challenge

                “High Equipment Costs Hindering Market Penetration”

• The substantial costs associated with advanced diagnostic tools and treatment options for hydronephrosis pose a significant barrier, particularly in low-income and developing regions
• Expenses related to imaging technologies, surgical interventions, and long-term management can limit patient access to necessary care

For instance,

• In May 2023, a study in Tanzania highlighted how the cost of advanced imaging and surgical procedures for hydronephrosis, exceeding USD 18,260, limits access to care in low-income regions. 
• Addressing these financial challenges is crucial to ensure equitable access to hydronephrosis diagnosis and treatment worldwide

Hydronephrosis Market Scope

The market is segmented on the basis of indication, treatment, type and diagnosis.

In 2025, the shock wave lithotripsy is projected to dominate the market with a largest share in Treatment segment

The shock wave lithotripsy segment is projected to dominate the hydronephrosis treatment market, holding the largest share of approximately 40.5% in 2025. This dominance is attributed to its non-invasive nature, high efficacy in treating kidney stones—a leading cause of hydronephrosis—and patient preference for procedures with minimal discomfort and shorter recovery times. As the global incidence of kidney stones continues to rise, the demand for effective and less invasive treatment options such as shock wave lithotripsy is expected to grow, further solidifying its market leadership.

The imaging is expected to account for the largest share during the forecast period in diagnosis market

In 2025, the imaging segment is expected to dominate the market with the largest market share of 64.2% due to the critical role of imaging techniques in diagnosing hydronephrosis. Imaging modalities such as ultrasound, CT scans, and MRI provide detailed visualization of the kidneys and urinary tract, enabling accurate assessment of the condition. The non-invasive nature, accessibility, and rapid results of imaging techniques make them the preferred choice for both patients and healthcare providers in diagnosing hydronephrosis.

Hydronephrosis Market Regional Analysis

“North America Holds the Largest Share in the Hydronephrosis Market”

• North America leads the global hydronephrosis market, accounting for approximately 42.6% of the market share. This dominance is attributed to advanced healthcare infrastructure, high adoption of innovative surgical technologies, and significant healthcare expenditure
• Within North America, U.S. is projected to dominate the global hydronephrosis market with estimated market share of 30.5%, due to its advanced healthcare infrastructure, high prevalence of kidney diseases, and substantial healthcare expenditure
• Well-established reimbursement frameworks in North America support the adoption of hydronephrosis treatment procedures, making them more accessible to patients and encouraging healthcare providers to offer these services

“Asia-Pacific is Projected to Register the Highest CAGR in the Hydronephrosis Market”

• Asia-Pacific is expected to witness the highest growth rate about 30.3% in the hydronephrosis market, driven by increasing healthcare investments, rising awareness about urinary tract disorders, and a growing geriatric population in countries such as China, India, and Japan
• Countries such as China, India, and Brazil are emerging as key markets in the global hydronephrosis market, primarily due to rising incidences of kidney-related disorders, expanding healthcare infrastructure, and improved access to diagnostic imaging in both urban and rural areas
• China is investing heavily in advanced medical technologies and urology departments in public hospitals, making it a major contributor to the Asia-Pacific region’s expansion in this market. The country's aging population and rising prevalence of urological disorders further drive demand.
• India is projected to register the highest CAGR of 4.1% in the hydronephrosis market, driven by factors such as the increasing prevalence of kidney-related disorders, expanding healthcare infrastructure, and improved access to diagnostic imaging in both urban and rural areas

Hydronephrosis Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Amgen Inc. (U.S.)
• Sanofi (France)
• Novartis AG (Switzerland)
• Pfizer Inc. (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Boston Scientific Corporation (U.S.)
• B. Braun SE (Germany)
• Stryker (U.S.)
• Zimmer Biomet (U.S.)
• Smith+Nephew (U.K.)
• Promega Corporation (U.S.)
• Merck KGaA (Germany)
• Medtronic (Ireland)
• Johnson & Johnson Services, Inc. (U.S.)
• AbbVie Inc. (U.S.)
• Cook (U.S.)

Latest Developments in Global Hydronephrosis Market

• In April 2025, a novel suture-free nephroplication technique was introduced for treating benign giant hydronephrosis. This method utilizes a 4D-printed biodegradable net bag to compress and fold the dilated kidney, simplifying and standardizing surgical procedures. Initial clinical applications have shown promising results, suggesting a potential alternative to nephrectomy in certain cases
• In January 2025, a comprehensive review highlighted ongoing research into novel therapies and minimally invasive methods for pediatric hydronephrosis. The integration of advanced imaging techniques, personalized treatment strategies, and emerging technologies aims to enhance management and improve long-term renal function in affected children
• In May 2025, the Asia-Pacific region was identified as a key area of growth for the hydronephrosis treatment market. Factors contributing to this expansion include improving healthcare access, rising awareness, and increasing adoption of advanced diagnostic and treatment modalities
• In May 2025, experts noted that while advancements in treatment options are promising, challenges such as high treatment costs and limited awareness in certain regions may impact accessibility. Ongoing efforts are focused on addressing these barriers to ensure equitable healthcare delivery
• In May 2025, the hydronephrosis market is expected to continue its upward trajectory, driven by technological innovations, increasing healthcare investments, and growing awareness about kidney health. The integration of digital health solutions and personalized medicine is anticipated to further shape the market landscape in the coming years       

SKU-13210